Q4 2024 Earnings Conference Call March 3, 2025 12:00 PM ETCompany ParticipantsTed Koenig - Chief Executive Officer of ...

Amid criticism of the California's oversight of its legal cannabis industry, calls are now mounting to strip many ...

This aviation services stock is back near a high after the company's turnaround earnings report last week. The company is ...

Relive the magic of March Madness with the top 10 buzzer-beaters in NCAA history! From Bryce Drew’s unforgettable moment with Valparaiso to Kris Jenkins’ legendary national championship-winning shot ...

NAV $8.85 per share. Chief Executive Officer Theodore L. Koenig commented, “We are pleased to announce that we paid a $0.25 per ...

The legal battle over Adnan Syed 's conviction, scrutinized a decade ago in the hit podcast “Serial,” keeps twisting and ...

The American people had the same reaction when failed Vice Presidential candidate Tim Walz suggested he might run for ...

After having ranked the top 10 offenses and top 10 rotations in our leadup to Opening Day, it's now time for the top 10 ...

Therapeutics announced it has entered into a license and distribution agreement with CSL Seqirus for the exclusive rights to ...

Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales –ANN ARBOR, Mich., March 03, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics ...

Texas parents were left outraged when their middle school-aged children came home from class with tattoos. Ashley Armstrong ...

MacroGenics Inc. (MGNX)股价跌至52周新低，触及$2.31，与其52周高点$21.88形成鲜明对比。根据 InvestingPro 分析，该公司目前显示估值偏低，其贝塔值为2.01，表明相对于大盘具有显著波动性。最新价格水平反映出与此前估值相比出现大幅下跌，该股票一年来暴跌87.09%。这一急剧下跌凸显了MacroGenics艰难的一年，公司正在努力应对市场动态和内部挑战，这 ...